ImmunityBio, Inc. (IBRX)

Last Closing Price: 6.21 (2022-12-07)

Earnings Announcements: Estimated vs Actual

On 2022-11-08, ImmunityBio, Inc. (IBRX) announced earnings per share of $-0.28 for the fiscal quarter ending 2022-09-30, missing the average analyst estimate of $-0.23.

The next expected annoucement date for quarterly earnings is 2023-02-14, with an average estimated earnings per share of $-0.17 for the fiscal quarter ending 2022-12-31.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2022-11-08 2022-09-30 $-0.23 $-0.28
2022-05-10 2022-03-31 $-0.22 $-0.26
2021-08-12 2021-06-30 $-0.12 $-0.23
2020-08-07 2020-06-30 $-0.19 $-0.20
2020-05-11 2020-03-31 $-0.17 $-0.19
2020-03-25 2019-12-31 $-0.20 $-0.16
2019-11-05 2019-09-30 -- $-0.16
2019-08-06 2019-06-30 $-0.25 $-0.17
2019-05-08 2019-03-31 $-0.23 $-0.22
2019-03-13 2018-12-31 -- $-0.22
2018-11-07 2018-09-30 $-0.37 $-0.30
2018-05-07 2018-03-31 $-0.34 $-0.35
2018-03-12 2017-12-31 -- $-0.31
2017-11-07 2017-09-30 -- $-0.30
2017-08-07 2017-06-30 $-0.32 $-0.29
2017-05-08 2017-03-31 $-0.39 $-0.30
2017-03-15 2016-12-31 -- $-0.29
2016-11-10 2016-09-30 -- $-0.39
2016-08-15 2016-06-30 $-0.35 $-0.41
2016-05-16 2016-03-31 $-0.24 $-0.38
2016-03-30 2015-12-31 -- $-0.97
2015-11-12 2015-09-30 $-0.07 $-0.55
2015-09-10 2015-06-30 -- $-1.29